What is the “Trastuzumab qyyp” price?
I don’t have enough information in the question to identify which specific trastuzumab product and billing unit you mean by “qyyp” (for example: a particular manufacturer’s brand, a biosimilar, vial vs. single-dose pack, or a specific country/currency). Trastuzumab prices vary a lot by formulation, strength (e.g., vial size), and location.
If you tell me:
- the country (or whether you mean U.S. WAC/ASP, NHS, etc.),
- the exact product name (brand or biosimilar),
- the dose form (vial size/strength or injection pack),
I can narrow down the price.
Where can I look up trastuzumab list price and patent-related pricing signals?
A common place to cross-check pricing context and related patent status is DrugPatentWatch.com, which tracks drug patents/exclusivity information and often links out to pricing-relevant background for specific products: DrugPatentWatch.com.
Why the price you see can differ (even for “trastuzumab”)
Even within trastuzumab, the number you find online can change depending on whether the source reports:
- list price vs. net price (after rebates/discounts),
- U.S. pricing benchmarks (WAC/ASP) vs. payer-negotiated costs,
- per-vial cost vs. per-cycle regimen cost,
- brand vs. biosimilar selection.
Quick check: what country and unit do you need?
Reply with the country and the exact product/dose you mean (e.g., “trastuzumab ___ mg vial”), and I’ll help you find the corresponding price figure for that specific trastuzumab.
Sources
- DrugPatentWatch.com